These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18575372)

  • 1. [Unexpected study data for treatment of hypertension. Combination therapy with a diuretic not imperative].
    Aumiller J
    MMW Fortschr Med; 2008 Jun; 150(23):46-7. PubMed ID: 18575372
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons from the ACCOMPLISH trial.
    Izzo JL
    Pol Arch Med Wewn; 2009 Jun; 119(6):344-6. PubMed ID: 19694213
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
    Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks].
    Praxis (Bern 1994); 2004 Oct; 93(42):1748. PubMed ID: 15529964
    [No Abstract]   [Full Text] [Related]  

  • 5. The Avoiding Cardiovascular events through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a comparison of first-line combination therapies.
    Weder AB
    Expert Opin Pharmacother; 2005 Feb; 6(2):275-81. PubMed ID: 15757423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24-hour ambulatory blood pressure in the ACCOMPLISH trial.
    Jamerson KA; Bakris GL; Weber MA
    N Engl J Med; 2010 Jul; 363(1):98. PubMed ID: 20592305
    [No Abstract]   [Full Text] [Related]  

  • 7. [ALLHAT--the most comprehensive antihypertensive treatment trial in the world. The significance of thiazide diuretics for patients older than 55 years is confirmed].
    Nilsson P
    Lakartidningen; 2003 Feb; 100(6):400-4, 407. PubMed ID: 12607431
    [No Abstract]   [Full Text] [Related]  

  • 8. [ASCOT-BPLA Study raises new questions regarding: which is the best initial antihypertensive drug?].
    MMW Fortschr Med; 2005 Sep; 147(39):12. PubMed ID: 16245771
    [No Abstract]   [Full Text] [Related]  

  • 9. [High dose sartan plus diuretic. More power in hypertension and its sequelae].
    MMW Fortschr Med; 2003 Mar; 145(11):59. PubMed ID: 12688201
    [No Abstract]   [Full Text] [Related]  

  • 10. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
    Melian EB; Jarvis B
    Drugs; 2002; 62(5):787-816. PubMed ID: 11929332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of a diuretic added to diltiazem.
    MacGregor GA; Cappuccio FP
    J Hum Hypertens; 1997 Apr; 11(4):249-50. PubMed ID: 9185031
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of the ASCOT-BPLA trial: no practical implications for treatment of hypertension.
    Prescrire Int; 2006 Jun; 15(83):112. PubMed ID: 16764103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure].
    MMW Fortschr Med; 2004 Apr; 146(14):45. PubMed ID: 15344757
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
    Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
    Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifty years of thiazide diuretic therapy for hypertension.
    Moser M; Feig PU
    Arch Intern Med; 2009 Nov; 169(20):1851-6. PubMed ID: 19901136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
    Weber MA; Jamerson K; Bakris GL; Weir MR; Zappe D; Zhang Y; Dahlof B; Velazquez EJ; Pitt B
    Lancet; 2013 Feb; 381(9866):537-45. PubMed ID: 23219284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valsartan/hydrochlorothiazide: a review of its pharmacology, therapeutic efficacy and place in the management of hypertension.
    Wellington K; Faulds DM
    Drugs; 2002; 62(13):1983-2005. PubMed ID: 12215069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular events during differing hypertension therapies in patients with diabetes.
    Weber MA; Bakris GL; Jamerson K; Weir M; Kjeldsen SE; Devereux RB; Velazquez EJ; Dahlöf B; Kelly RY; Hua TA; Hester A; Pitt B;
    J Am Coll Cardiol; 2010 Jun; 56(1):77-85. PubMed ID: 20620720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide.
    Kjeldsen SE; Os I; Høieggen A; Beckey K; Gleim GW; Oparil S
    Am J Cardiovasc Drugs; 2005; 5(1):17-22. PubMed ID: 15631534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.